If you made any changes in Pure these will be visible here soon.

Research Output

2019

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Mehanna, H., Robinson, M., Hartley, A., Kong, A., Foran, B., Fulton-Lieuw, T., Dalby, M., Mistry, P., Sen, M., O'Toole, L., Al Booz, H., Dyker, K., Moleron, R., Whitaker, S., Brennan, S., Cook, A., Griffin, M., Aynsley, E., Rolles, M., de Winton, E. & 31 others, Chan, A., Srinivasan, D., Nixon, I., Grumett, J., Leemans, C. R., Buter, J., Henderson, J., Harrington, K., McConkey, C., Gray, A., Dunn, J., Moleron, R., McArdle, O., Dyker, K., Al Booz, H., O'Toole, L., Cook, A., Husband, D., Loo, V., Soe, W., Aynsley, E., Sridhar, T., Jankowska, P., Joseph, M., Geropantas, K., Vaidya, D., Griffin, M., Hartley, A., Vijayan, R., Buter, J. & De-ESCALaTE HPV Trial Group, 5 Jan 2019, In : Lancet. 393, 10166, p. 51-60 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2018

Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

Boon, E., van Boxtel, W., Buter, J., Baatenburg de Jong, R. J., van Es, R. J. J., Bel, M., Fiets, E., Oosting, S. F., Slingerland, M., Hoeben, A., Tesselaar, M. E. T., Jonker, M. A., Flucke, U. E., van der Graaf, W. T. A. & van Herpen, C. M. L., 1 Mar 2018, In : Head and Neck. 40, 3, p. 605-613 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapy

Melissant, H. C., Jansen, F., Schutte, L. E. R., Lissenberg-Witte, B. I., Buter, J., Leemans, C. R., Sprangers, M. A., Vergeer, M. R., Laan, E. T. M. & Verdonck-de Leeuw, I. M., 1 Aug 2018, In : Oral Oncology. 83, p. 120-126 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2017

1070PComparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

Hanemaaijer, S. H., Kok, I. C., Fehrmann, R. S. N., van der Vegt, B., Gietema, J. A., Plaat, B. E. C., Vugt, M. A. T. M., Vergeer, M. R., Voortman, J., Leemans, C. R., Buter, J., Langendijk, J. A. & Oosting, S. F., 1 Sep 2017, In : Annals of Oncology. 28, suppl_5

Research output: Contribution to journalArticleAcademicpeer-review

Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'

Hanemaaijer, S. H., Kok, I. C., Fehrmann, R. S. N., van der Vegt, B., Gietema, J. A., Plaat, B. E. C., Vugt, M. A. T. M., Vergeer, M. R., Voortman, J., Leemans, C. R., Buter, J., Langendijk, J. A. & Oosting, S. F., Sep 2017, In : Annals of Oncology. 28

Research output: Contribution to journalMeeting AbstractAcademic

Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck

van Weert, S., Reinhard, R., Bloemena, E., Buter, J., Witte, B. I., Vergeer, M. R. & Leemans, C. R., 1 Mar 2017, In : Head and Neck. 39, 3, p. 456-463 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults

Boon, E., van der Graaf, W. T. A., Gelderblom, H., Tesselaar, M. E. T., van Es, R. J. J., Oosting, S. F., de Bree, R., van Meerten, E., Hoeben, A., Smeele, L. E., Willems, S. M., Witjes, M. J. H., Buter, J., Baatenburg de Jong, R. J., Flucke, U. E., Peer, P. G. M., Bovée, J. V. M. G. & Van Herpen, C. M. L., 1 Jan 2017, In : Head and Neck. 39, 1, p. 140-146 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Long survival of patients with locally advanced breast cancer on combined neoadjuvant chemotherapy and immune potentiation: Modern lessons from an old study

Pohlmann, P. R., van Cruijsen, H., Stam, A. G. M., Lougheed, S. M., van den Eertwegh, A. J. M., Hoekman, K., Scheper, R., Buter, J., van der Hoeven, J. J. M., van der Wall, E., Pinedo, H. M. & de Gruij, T. D., Feb 2017, In : Cancer Research. 77

Research output: Contribution to journalArticleAcademicpeer-review

2016

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma

van Linde, M. E., van der Mijn, J. C., Pham, T. V., Knol, J. C., Wedekind, L. E., Hovinga, K. E., Aliaga, E. S., Buter, J., Jimenez, C. R., Reijneveld, J. C. & Verheul, H. M. W., Sep 2016, In : Journal of Neuro-Oncology. 129, 2, p. 221-230

Research output: Contribution to journalArticleAcademicpeer-review

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Erdem-Eraslan, L., van den Bent, M. J., Hoogstrate, Y., Naz-Khan, H., Stubbs, A., van der Spek, P., Böttcher, R., Gao, Y., de Wit, M., Taal, W., Oosterkamp, H. M., Walenkamp, A., Beerepoot, L. V., Hanse, M. C. J., Buter, J., Honkoop, A. H., van der Holt, B., Vernhout, R. M., Sillevis Smitt, P. A. E., Kros, J. M. & 1 others, French, P. J., 1 Feb 2016, In : Cancer Research. 76, 3, p. 525-34 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer

Heukelom, J., Lopez-Yurda, M., Balm, A. J. M., Wijers, O. B., Buter, J., Gregor, T., Wiggenraad, R., de Boer, J. P., Tan, I. B., Verheij, M., Sonke, J-J. & Rasch, C. R., Apr 2016, In : Head and Neck. 38 Suppl 1, p. E488-93

Research output: Contribution to journalArticleAcademicpeer-review

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis

Holla, F. K., Postma, T. J., Blankenstein, M. A., van Mierlo, T. J. M., Vos, M. J., Sizoo, E. M., de Groot, M., Uitdehaag, B. M. J., Buter, J., Klein, M., Reijneveld, J. C. & Heimans, J. J., Sep 2016, In : Journal of Neuro-Oncology. 129, 3, p. 525-532

Research output: Contribution to journalArticleAcademicpeer-review

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

van der Linden, N., Buter, J., Pescott, C. P., Lalisang, R. I., de Boer, J. P., de Graeff, A., van Herpen, C. M. L., Baatenburg de Jong, R. J. & Uyl-de Groot, C. A., Feb 2016, In : European Archives of Oto-Rhino-Laryngology. 273, 2, p. 455-64 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

2015

Een ongewoon seminoom

Mensink, A. S. B., Buter, J. & Rozendaal, L., 2015, In : Nederlands Tijdschrift voor Oncologie. 12, 3, p. 109-112

Research output: Contribution to journalArticleProfessional

Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck

van der Linden, N., van Gils, C. W. M., Pescott, C. P., Buter, J., Vergeer, M. R. & Uyl-de Groot, C. A., 2015, In : European Archives of Oto-Rhino-Laryngology. 272, 8, p. 2007-2016

Research output: Contribution to journalArticleAcademicpeer-review

Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review

van der Putten, L., de Bree, R., Doornaert, P., Buter, J., Eerenstein, S. E. J., Rietveld, D. H. F., Kuik, D. J. & Leemans, C. R., 2015, In : Acta otorhinolaryngologica italica. 35, 3, p. 162-172

Research output: Contribution to journalArticleAcademicpeer-review

2014

Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study

Froklage, F. E., Oosterbaan, L. J., Sizoo, E. M., de Groot, M., Bosma, I., Sanchez, E., Douw, L., Heimans, J. J., Reijneveld, J. C., Lagerwaard, F. J., Buter, J., Uitdehaag, B. M. J., Klein, M. & Postma, T. J., 2014, In : Journal of Neuro-Oncology. 116, 2, p. 387-394

Research output: Contribution to journalArticleAcademicpeer-review

Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results

van der Linden, N., van Gils, C. W. M., Pescott, C. P., Buter, J. & Uyl-de Groot, C. A., 2014, In : European Archives of Oto-Rhino-Laryngology. 271, 6, p. 1673-1678

Research output: Contribution to journalArticleAcademicpeer-review

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

Taal, W., Oosterkamp, H. M., Walenkamp, A. M. E., Dubbink, H. J., Beerepoot, L. V., Hanse, M. C. J., Buter, J., Honkoop, A. H., Boerman, D., de Vos, F. Y. F., Dinjens, W. N. M., Enting, R. H., Taphoorn, M. J. B., van den Berkmortel, F. W. P. J., Jansen, R. L. H., Brandsma, D., Bromberg, J. E. C., van Heuvel, I., Vernhout, R. M., van der Holt, B. & 1 others, van den Bent, M. J., 2014, In : Lancet Oncology. 15, 9, p. 943-953

Research output: Contribution to journalArticleAcademicpeer-review

The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: A prospective cohort study.

Verdonck-de Leeuw, I. M., Buffart, L. M., Heijmans, M. W., Rietveld, D. H. F., Doornaert, P., de Bree, R., Buter, J., Aaronson, N. K., Slotman, B. J., Leemans, C. R. & Langendijk, J. A., 2014, In : Radiotherapy and Oncology. 110, 3, p. 422-428 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2013

IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation

Lindenberg, J. J., Oosterhoff, D., Sombroek, C. C., Lougheed, S. M., Hooijberg, E., Stam, A. G. M., Santegoets, S. J. A. M., Tijssen, H. J., Buter, J., Pinedo, H. M., van den Eertwegh, A. J. M., Scheper, R. J., Koenen, H. J. P. M., van de Ven, R. & de Gruijl, T. D., 2013, In : PLoS ONE. 8, 7, e70237.

Research output: Contribution to journalArticleAcademicpeer-review

Recurrent dyspnea following a swollen leg in a 46-year-old man

Post, J. P., Westgeest, H. M., Blankensteijn, J. D., van der Meijs, B., Klaassen, R. J. L., Nossent, E., Grünberg, K., Buter, J. & Serné, E. H., 2013, In : Chest. 144, 4, p. 1402-1405

Research output: Contribution to journalArticleAcademicpeer-review

2012

Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice

Cnossen, I. C., de Bree, R., Rinkel, R. N. P. M., Eerenstein, S. E. J., Rietveld, D. H. F., Doornaert, P. A. H., Buter, J., Langendijk, J. A., Leemans, C. R. & de Leeuw, I. M., 2012, In : Supportive Care in Cancer. 20, 11, p. 2925-2931

Research output: Contribution to journalArticleAcademicpeer-review

MRI and thallium-201 SPECT in the prediction of survival in glioma

Vos, M. J., Berkhof, J., Hoekstra, O. S., Bosma, I., Sizoo, E. M., Heimans, J. J., Reijneveld, J. C., Sanchez, E., Lagerwaard, F. J., Buter, J., Noske, D. P. & Postma, T. J., 2012, In : Neuroradiology. 54, 6, p. 539-546

Research output: Contribution to journalArticleAcademicpeer-review

2011

Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy

Garrett, C. R., Siu, L. L., El-Khoueiry, A., Buter, J., Rocha-Lima, C. M., Marshall, J., LoRusso, P., Major, P., Chemidlin, J., Mokliatchouk, O., Velasquez, L., Hayes, W., Feltquate, D., Syed, S., Ford, S., Kollia, G., Galbraith, S. & Nuyten, D. S. A., 2011, In : British Journal of Cancer. 105, 1, p. 44-52

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
51 Downloads (Pure)

Salvage laryngectomy: Oncological and functional outcome

van der Putten, L., de Bree, R., Kuik, D. J., Rietveld, D. H. F., Buter, J., Eerenstein, S. E. J. & Leemans, C. R., 2011, In : Oral Oncology. 47, 4, p. 296-301

Research output: Contribution to journalArticleAcademicpeer-review

Tumor Volume As Prognostic Factor in Chemoradiation for Advanced Head and Neck Cancer

Knegjens, J. L., Hauptmann, M., Pameijer, F. A., Balm, A. J., Hoebers, F. J., de Bois, J. A., Kaanders, J. H., van Herpen, C. M., Verhoef, C. G., Wijers, O. B., Wiggenraad, R. G., Buter, J. & Rasch, C. R., 2011, In : Head and Neck. 33, 3, p. 375-382

Research output: Contribution to journalArticleAcademicpeer-review

2010

Beloop en beleid bij vermoeden van een laaggradig glioom

Sizoo, E. M., Reijneveld, J. C., Lagerwaard, F. J., Buter, J., Taphoorn, M. J. B. & Versélewel de Witt Hamer, P. C., 2010, In : Nederlands Tijdschrift voor Geneeskunde. 154, A1367.

Research output: Contribution to journalArticleProfessional

Caregiver Demands and Caregiver Mastery in Partners of High-Grade Glioma Patients

Hoeben, W., Hilverda, K., Heimans, J. J., Taphoorn, M. J. B., Postma, T. J., Buter, J., Lenting, J., Collette, E. H., Reijneveld, J. C. & Klein, M., 2010, In : Neuro-Oncology. 12, p. 102-102

Research output: Contribution to journalMeeting AbstractOther research output

File
59 Downloads (Pure)

Intra-arterial Versus Intravenous Chemoradiation for Advanced Head and Neck Cancer: Results of a Randomized Phase 3 Trial

Rasch, C. R. N., Hauptmann, M., Schornagel, J., Wijers, O., Buter, J., Gregor, T., Wiggenraad, R., de Boer, J. P., Ackerstaff, A. H., Kroger, R., Hoebers, F. J. P. & Balm, A. J. M., 2010, In : Cancer. 116, 9, p. 2159-2165

Research output: Contribution to journalArticleAcademicpeer-review

Mri and Thallium-201 Spect in the Prediction of Outcome in Glioma Therapy

Vos, M. J., Berkhof, J., Hoekstra, O. S., Bosma, I., Sizoo, E. M., Heimans, J. J., Reijneveld, J. C., Sanchez, E., Lagerwaard, F. J., Buter, J., Noske, D. P. & Postma, T. J., 2010, In : Neuro-Oncology. 12, p. 35-35

Research output: Contribution to journalMeeting AbstractOther research output

Predictors of Quality of Life of Partners of High-Grade Glioma Patients

Hoeben, W., Hilverda, K., Heimans, J. J., Taphoorn, M. J. B., Postma, T. J., Buter, J., Lenting, J., Collette, E. H., Reijneveld, J. C. & Klein, M., 2010, In : Neuro-Oncology. 12, p. 18-18

Research output: Contribution to journalMeeting AbstractOther research output

Serum S-100B Protein Is A Predictor of Survival in Recurrent Glioma

van Mierlo, T. J. M., Postma, T. J., Vos, M. J., Uitdehaag, B. M. J., Blankenstein, R. A., Buter, J., Reijneveld, J. C. & Heimans, J. J., 2010, In : Neuro-Oncology. 12, p. 32-32

Research output: Contribution to journalMeeting AbstractOther research output

2009

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma

Nutting, C. M., van Herpen, C. M. L., Miah, A. B., Bhide, S. A., Machiels, J. P., Buter, J., Kelly, C., de Raucourt, D. & Harrington, K. J., 2009, In : Annals of Oncology. 20, 7, p. 1275-1279

Research output: Contribution to journalArticleAcademicpeer-review

2008

Medicamenteuze behandeling van maligne tumoren

Buter, J., 2008, In : Nederlands Tijdschrift voor Tandheelkunde. 115, 4, p. 201-202

Research output: Contribution to journalArticleProfessional

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)

van Herpen, C. M. L., Locati, L. D., Buter, J., Thomas, J., Bogaerts, J., Lacombe, D., Mulder, P., Awada, A., Licitra, L., Bernier, J. & Vermorken, J. B., 2008, In : European Journal of Cancer. 44, 17, p. 2542-2545

Research output: Contribution to journalArticleAcademicpeer-review

Subsequent tumors in retinoblastoma survivors: the role of the head and neck surgeon

de Bree, R., Moll, A. C., Imhof, S. M., Buter, J. & Leemans, C. R., 2008, In : Oral Oncology. 44, 10, p. 982-985

Research output: Contribution to journalArticleAcademicpeer-review

2006

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

Tijink, B. M., Buter, J., De Bree, R., Giaccone, G., Lang, M. S., Staab, A., Leemans, C. R. & Van Dongen, G. A. M. S., 15 Oct 2006, In : Clinical Cancer Research. 12, 20 PART 1, p. 6064-6072 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance

de Gruijl, T. D., Sombroek, C. C., Lougheed, S. M., Oosterhoff, D., Buter, J., van den Eertwegh, A. J. M., Scheper, R. J. & Pinedo, H. M., 15 Jun 2006, In : Journal of Immunology. 176, 12, p. 7232-42 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

2004

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature

Langendijk, J. A., Leemans, C. R., Buter, J., Berkhof, J. & Slotman, B. J., 1 Dec 2004, In : Journal of Clinical Oncology. 22, 22, p. 4604-4612 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2003

Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells

Pinedo, H. M., Buter, J., Luykx-de Bakker, S. A., Pohlmann, P. R., van Hensbergen, Y., Heideman, D. A. M., van Diest, P. J., de Gruijl, T. D. & van der Wall, E., May 2003, In : European Journal of Cancer. 39, 8, p. 1061-7 7 p.

Research output: Contribution to journalArticleAcademicpeer-review